NCT07351370

Brief Summary

Τhe aim of this randomized clinical trial was to investigate the efficacy of two daily mouth rinses containing CHX and different combinations of H2O2 and CPC, when used adjunctive to mechanical oral hygiene, and compare them with a placebo mouth rinse. The primary outcomes evaluated were changes in i) bacterial biofilm accumulation, ii) gingival inflammation, and iii) tooth staining. Secondarily, patient's satisfaction and perspective after the use of these formulations was assessed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Jan 2022

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 20, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 20, 2022

Completed
3.5 years until next milestone

First Submitted

Initial submission to the registry

January 4, 2026

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 20, 2026

Completed
Last Updated

April 8, 2026

Status Verified

April 1, 2026

Enrollment Period

6 months

First QC Date

January 4, 2026

Last Update Submit

April 2, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • change in plaque index (PI)

    change in dental plaque accumulation assessed using the plaque index (PI)

    baseline, 1 month, 2 months and 3 months

Study Arms (3)

chlorhexidine 0.05% + cetylpyridinium chloride 0.05% and hydrogen peroxide 0.8%

EXPERIMENTAL

Participants rinsed twice daily for 3 months with a mouthwash containing chlorhexidine 0.05% + cetylpyridinium chloride 0.05% and hydrogen peroxide 0.8% , as adjunct to conventional mechanical oral hygiene. All participants received supragingival prophylaxis and oral hygiene reinforcement prior to the intervention.

Drug: chlorhexidine/ cetylpyridinium chloride/ hydrogen peroxide mouthwash

CHX 0.05% + CPC 0.05%

EXPERIMENTAL

Participants rinsed twice daily for 3 months with a mouthwash containing chlorhexidine 0.05% and cetylpyridinium chloride 0.05% , as adjunct to conventional mechanical oral hygiene. All participants received supragingival prophylaxis and oral hygiene reinforcement prior to the intervention.

Drug: Chlorhexidine/ cetylpyridinium chloride

placebo mouthwash

PLACEBO COMPARATOR

Participants rinsed twice daily for 3 months with placebo mouthwash, as adjunct to conventional mechanical oral hygiene. All participants received supragingival prophylaxis and oral hygiene reinforcement prior to the intervention.

Other: Placebo

Interventions

PlaceboOTHER

All participants were instructed to rinse for 3 months for 1 minute twice a day with 15 ml of the provided solution

placebo mouthwash

All participants were instructed to rinse for 3 months for 1 minute twice a day with 15 ml of the provided solution

CHX 0.05% + CPC 0.05%

All participants were instructed to rinse for 3 months for 1 minute twice a day with 15 ml of the provided solution.

chlorhexidine 0.05% + cetylpyridinium chloride 0.05% and hydrogen peroxide 0.8%

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients (≥18 years old)
  • Presence of at least 24 teeth
  • Presence of teeth #23-13 and #43-33
  • Gingival Index (GI) ≤30% (Lindhe, 1981)
  • No interdental clinical attachment loss (CAL) at ≥2 non-adjacent teeth or buccal/oral CAL ≥3 mm with probing pocket depth (PPD) \>3 mm at ≥2 teeth (Tonetti et al., 2019)
  • No known allergy to chlorhexidine (CHX), hydrogen peroxide (H₂O₂), or cetylpyridinium chloride (CPC)
  • No fixed or removable orthodontic appliances or removable prostheses
  • No use of systemic antibiotics within the 3 months prior to the study
  • Non-smokers or light smokers (\<5 cigarettes/day)
  • Non-pregnant and non-lactating women
  • Absence of crowns, fixed partial dentures, or class III/IV/V composite restorations covering more than one-third of the crown, and no deep dental caries extending into dentine

You may not qualify if:

  • Presented with signs of hypersensitivity, severe irritation, or discomfort during the experimental period
  • Were not compliant with the experimental protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NKUA School of Dentistry

Athens, Attica, Greece

Location

MeSH Terms

Conditions

Dental PlaquePeriodontal Diseases

Interventions

ChlorhexidineCetylpyridinium

Condition Hierarchy (Ancestors)

Dental DepositsTooth DiseasesStomatognathic DiseasesMouth Diseases

Intervention Hierarchy (Ancestors)

BiguanidesGuanidinesAmidinesOrganic ChemicalsPyridinium CompoundsPyridinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
double-blinding study. This means that neither the participants, their caregivers, nor the researchers processing the data or evaluating the results know which participant is receiving which of the three different mouth rinses. Additionally, it seems that the rinses were placed in plastic containers of the same color and labeling, so neither the participants nor the researchers know which container contains which rinse, achieving complete blinding.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The interventional study model is a single-center, randomized, controlled, double-blind, parallel-design clinical trial spanning over 3 months. It compares the efficacy of two mouth rinses: 1) CHX 0.05% + CPC 0.05% + H2O2 0.8%, and 2) CHX 0.05% + CPC 0.05%, with a placebo. Participants undergo screening, sign consent forms, and receive oral hygiene instructions before being randomly allocated to one of the three groups. They rinse twice daily for 3 months, and oral health parameters are assessed at baseline and monthly intervals. Compliance is monitored, and potential side effects are evaluated. Participants provide feedback via a questionnaire at the trial's end.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 4, 2026

First Posted

January 20, 2026

Study Start

January 15, 2022

Primary Completion

July 20, 2022

Study Completion

July 20, 2022

Last Updated

April 8, 2026

Record last verified: 2026-04

Locations